Multiplex Polymerase Chain Reaction/Pooled Antibiotic Susceptibility Testing Was Not Associated with Increased Antibiotic Resistance in Management of Complicated Urinary Tract Infections
Howard J Korman,Mohit Mathur,Natalie Luke,Dakun Wang,Xihua Zhao,Michael Levin,David L Wenzler,David Baunoch
DOI: https://doi.org/10.2147/IDR.S406745
2023-05-09
Infection and Drug Resistance
Abstract:Howard J Korman, 1 Mohit Mathur, 2 Natalie Luke, 2 Dakun Wang, 3 Xihua Zhao, 4 Michael Levin, 1 David L Wenzler, 1 David Baunoch 5 1 Comprehensive Urology Division, Michigan Healthcare Professionals, Royal Oak, MI, USA; 2 Department of Medical Affairs, Pathnostics, Irvine, CA, USA; 3 Department of Writing, Stat4Ward, Pittsburgh, PA, USA; 4 Department of Statistical Analysis, Stat4Ward, Pittsburgh, PA, USA; 5 Department of Research and Development, Pathnostics, Irvine, CA, USA Correspondence: Mohit Mathur, Pathnostics, 15545 Sand Canyon Suite 100, Irvine, CA, 92618, USA, Email Objective: To compare antibiotic resistance results at different time points in patients with urinary tract infections (UTIs), who were either treated based upon a combined multiplex polymerase chain reaction (M-PCR) and pooled antibiotic susceptibility test (P-AST) or were not treated. Methods: The M-PCR/P-AST test utilized here detects 30 UTI pathogens or group of pathogens, 32 antibiotic resistance (ABR) genes, and phenotypic susceptibility to 19 antibiotics. We compared the presence or absence of ABR genes and the number of resistant antibiotics, at baseline (Day 0) and 5– 28 days (Day 5– 28) after clinical management in the antibiotic-treated (n = 52) and untreated groups (n = 12). Results: Our results demonstrated that higher percentage of patients had a reduction in ABR gene detection in the treated compared to the untreated group (38.5% reduction vs 0%, p = 0.01). Similarly, significantly more patients had reduced numbers of resistant antibiotics, as measured by the phenotypic P-AST component of the test, in the treated than in the untreated group (42.3% reduction vs 8.3%, p = 0.04). Conclusion: Our results with both resistance gene and phenotypic antibiotic susceptibility results demonstrated that treatment based upon rapid and sensitive M-PCR/P-AST resulted in reduction rather than induction of antibiotic resistance in symptomatic patients with suspected complicated UTI (cUTI) in an urology setting, indicating this type of test is valuable in the management of these types of patients. Further studies of the causes of gene reduction, including elimination of ABR gene-carrying bacteria and loss of ABR gene(s), are warranted. Keywords: urinary tract infection, complicated urinary tract infection, antibiotic resistance, antibiotic resistance genes, diagnostic testing, polymerase chain reaction PCR-based diagnostic tests can reduce the time to results and improve sensitivity, but there are concerns that the increased sensitivity may lead to overtreatment and increase in antibiotic resistance, potentially preventing its wide clinical use for the diagnosis of complicated UTIs (cUTIs). 1–5 The rapid increase of resistant bacterial strains due to the overuse of antibiotics is one of the most serious health threats worldwide. 6–8 The bacterial population can resist antibiotics through a variety of mechanisms, including acquiring antibiotic resistance (ABR) genes, mutations to chromosomal target genes, active removal of drugs by efflux pumps, inactivation, or degradation of antibiotics, modifying bacterial cell wall to prevent antibiotics from reaching their target sites, and building biofilms. 9 To combat this health challenge, antimicrobial stewardship programs endorsed by the Centers for Disease Control and prevention (CDC) and World Health Organization (WHO), have been implemented to improve appropriate antibiotic utilization. Timely diagnosis and appropriate antibiotic selection are critical components of these antimicrobial stewardship programs. 10,11 UTIs are a leading cause for antibiotic prescriptions and a significant healthcare problem in the US, accounting for 10.5 million office visits and over $3.5 billion in healthcare costs per year. 12–16 While simple UTIs can be managed successfully with outpatient antibiotics, patients with complicated UTIs (cUTIs) have higher treatment failure rates and poor outcomes, including UTI recurrence. A typical initial diagnostic for UTIs is dipstick urinalysis, which provides rapid results and in conjunction with clinical findings can inform management decisions. In many cases, empiric broad spectrum antimicrobial therapy is initiated. 17 The selection of empiric antibiotics depends on susceptibility of prior urinary isolates, patient clinical circumstances (such as allergy, drug interaction, expected compliance, and tolerability), hospital and local community antibiotic resistance patterns, and other factors. 18 For cUTIs in the outpatient setting, current guidelines (Infectious Diseases S -Abstract Truncated-
pharmacology & pharmacy,infectious diseases